Literature DB >> 20034808

An early inflammatory response to oesophagectomy predicts the occurrence of pulmonary complications.

Xavier Benoit D'Journo1, Pierre Michelet, Valérie Marin, Isabelle Diesnis, Dorothée Blayac, Christophe Doddoli, Pierre Bongrand, Pascal Alexandre Thomas.   

Abstract

BACKGROUND: Respiratory complications are the most frequent concern following oesophagectomy. We aimed to assess the postoperative inflammatory response after oesophagectomy and to determine its reliability to predict the occurrence of pulmonary complications.
METHODS: A total of 97 patients were enrolled in this prospective observational study. All patients underwent a transthoracic oesophagectomy for cancer. From D0 to D3, plasmatic cytokine levels (interleukin (IL)-1, IL-6, IL-8, IL-10, tumour necrosis factor (TNF)-alpha), short synacthen test (SST), PaO(2)/FiO(2) ratio and clinical factors determining the systemic inflammatory response syndrome (SIRS) were monitored and compared between patients who experienced pulmonary complications (group I) and those who did not (group II).
RESULTS: The overall in-hospital mortality was 5%. Postoperative pulmonary complications occurred in 33 patients (34%). Sputum retention was the first step of pulmonary complications in 26 patients (occurring at a mean of 2.8+/-1 days after the operation), leading to pneumonia in 22 patients (4.7+/-1 days) and acute respiratory distress syndrome (ARDS) in 10 (6.9+/-3 days). At day 2, group I patients had significantly higher plasmatic levels of IL-6, IL-10 and TNF-alpha than group II patients. PaO(2)/FiO(2) was impaired accordingly (215 vs 348; p=0.006). SST was negative in 38% of group I patients and in 30% of group II patients (p=0.51). SIRS was present in 33% and 6% of group I and group II patients, respectively (p< or =0.01). At multivariate analysis, early occurrence of SIRS was the sole significant predictor of pulmonary complications (p=0.005; odds ratio (OR):11.4, confidence interval (CI): 2-63).
CONCLUSIONS: The vast majority of postoperative pulmonary complications after oesophagectomy occur after the 4th postoperative day. The earlier detection (first 48 h) of SIRS, high plasmatic cytokine levels and impairment of PaO(2)/FiO(2) predicts the onset of these complications. This finding suggests that early pharmacological intervention may have a beneficial impact. Copyright 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20034808     DOI: 10.1016/j.ejcts.2009.11.033

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  12 in total

1.  Effects of sevoflurane and propofol on pulmonary inflammatory responses during lung resection.

Authors:  Yusuke Sugasawa; Keisuke Yamaguchi; Seiichiro Kumakura; Taisuke Murakami; Kenji Suzuki; Isao Nagaoka; Eiichi Inada
Journal:  J Anesth       Date:  2011-10-07       Impact factor: 2.078

2.  Topography and extent of pulmonary vagus nerve supply with respect to transthoracic oesophagectomy.

Authors:  Teus J Weijs; Jelle P Ruurda; Misha D P Luyer; Grard A P Nieuwenhuijzen; Richard van Hillegersberg; Ronald L A W Bleys
Journal:  J Anat       Date:  2015-10       Impact factor: 2.610

3.  Usefulness of combining clinical and biochemical parameters for prediction of postoperative pulmonary complications after lung resection surgery.

Authors:  Ignacio Garutti; Francisco De la Gala; Patricia Piñeiro; Lisa Rancan; Elena Vara; Almudena Reyes; Luis Puente-Maestu; Jose María Bellón; Carlos Simón
Journal:  J Clin Monit Comput       Date:  2019-01-17       Impact factor: 2.502

4.  Prognostic Factors of Salvage Esophagectomy for Residual or Recurrent Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy.

Authors:  Yuki Kiyozumi; Naoya Yoshida; Takatsugu Ishimoto; Taisuke Yagi; Yuki Koga; Tomoyuki Uchihara; Hiroshi Sawayama; Yukiharu Hiyoshi; Masaaki Iwatsuki; Yoshifumi Baba; Yuji Miyamoto; Masayuki Watanabe; Tomohiko Matsuyama; Natsuo Oya; Hideo Baba
Journal:  World J Surg       Date:  2018-09       Impact factor: 3.352

Review 5.  New insights into the surgical anatomy of the esophagus.

Authors:  Teun J Weijs; Jelle P Ruurda; Michael D P Luyer; Miguel A Cuesta; Richard van Hillegersberg; Ronaldus L A W Bleys
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

6.  The effect of one-lung ventilation upon pulmonary inflammatory responses during lung resection.

Authors:  Yusuke Sugasawa; Keisuke Yamaguchi; Seiichiro Kumakura; Taisuke Murakami; Toyoki Kugimiya; Kenji Suzuki; Isao Nagaoka; Eiichi Inada
Journal:  J Anesth       Date:  2011-02-08       Impact factor: 2.078

7.  Kinetics of plasma biomarkers of inflammation and lung injury in surgical patients with or without postoperative pulmonary complications.

Authors:  Ary Serpa Neto; Pedro P Z A Campos; Sabrine N T Hemmes; Lieuwe D Bos; Thomas Bluth; Marion Ferner; Andreas Güldner; Markus W Hollmann; Inmaculada India; Thomas Kiss; Rita Laufenberg-Feldmann; Juraj Sprung; Demet Sulemanji; Carmen Unzueta; Marcos F Vidal Melo; Toby N Weingarten; Anita M Tuip-de Boer; Paolo Pelosi; Marcelo Gama de Abreu; Marcus J Schultz
Journal:  Eur J Anaesthesiol       Date:  2017-04       Impact factor: 4.330

8.  Effects of sevoflurane and propofol on the development of pneumonia after esophagectomy: a retrospective cohort study.

Authors:  Guo-Hua Zhang; Wen Wang
Journal:  BMC Anesthesiol       Date:  2017-12-04       Impact factor: 2.217

9.  Preventive effect of ulinastatin on postoperative complications, immunosuppression, and recurrence in esophagectomy patients.

Authors:  Lingmin Zhang; Ning Wang; Suna Zhou; Wenguang Ye; Qinglin Yao; Guixia Jing; Mingxin Zhang
Journal:  World J Surg Oncol       Date:  2013-04-10       Impact factor: 2.754

10.  Impact of reduced skeletal muscle volume on clinical outcome after esophagectomy for esophageal cancer: A retrospective study.

Authors:  Ken Nagata; Hironori Tsujimoto; Hiromi Nagata; Manabu Harada; Nozomi Ito; Kyohei Kanematsu; Shinsuke Nomura; Hiroyuki Horiguchi; Shuichi Hiraki; Kazuo Hase; Junji Yamamoto; Hideki Ueno
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.